These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31400997)

  • 1. Metabolic Score for Visceral Fat (METS-VF), a novel estimator of intra-abdominal fat content and cardio-metabolic health.
    Bello-Chavolla OY; Antonio-Villa NE; Vargas-Vázquez A; Viveros-Ruiz TL; Almeda-Valdes P; Gomez-Velasco D; Mehta R; Elias-López D; Cruz-Bautista I; Roldán-Valadez E; Martagón AJ; Aguilar-Salinas CA
    Clin Nutr; 2020 May; 39(5):1613-1621. PubMed ID: 31400997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DXA-Derived vs Standard Anthropometric Measures for Predicting Cardiometabolic Risk in Middle-Aged Australian Men and Women.
    Zhu K; Walsh JP; Murray K; Hunter M; Hui J; Hung J
    J Clin Densitom; 2022; 25(3):299-307. PubMed ID: 35177350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the usefulness of a newly proposed metabolic score for visceral fat in predicting future diabetes: results from the NAGALA cohort study.
    Yang R; Kuang M; Qiu J; Yu C; Sheng G; Zou Y
    Front Endocrinol (Lausanne); 2023; 14():1172323. PubMed ID: 37538796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between DXA-based and anthropometric measures of visceral fat and morbidity in women.
    Direk K; Cecelja M; Astle W; Chowienczyk P; Spector TD; Falchi M; Andrew T
    BMC Cardiovasc Disord; 2013 Apr; 13():25. PubMed ID: 23552273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Score for Visceral Fat (METS-VF) Estimation - A Novel Cost-Effective Obesity Indicator for Visceral Adipose Tissue Estimation.
    Kapoor N; Jiwanmall SA; Nandyal MB; Kattula D; Paravathareddy S; Paul TV; Furler J; Oldenburg B; Thomas N
    Diabetes Metab Syndr Obes; 2020; 13():3261-3267. PubMed ID: 32982356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study.
    Shah RV; Murthy VL; Abbasi SA; Blankstein R; Kwong RY; Goldfine AB; Jerosch-Herold M; Lima JA; Ding J; Allison MA
    JACC Cardiovasc Imaging; 2014 Dec; 7(12):1221-35. PubMed ID: 25440591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Score for Visceral Fat: A reliable indicator of visceral obesity for predicting risk for hypertension.
    Feng Y; Yang X; Li Y; Wu Y; Han M; Qie R; Huang S; Wu X; Zhang Y; Liu D; Hu F; Zhang M; Yang Y; Shi X; Lu J; Zhao Y; Hu D
    Nutrition; 2022 Jan; 93():111443. PubMed ID: 34563934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between metabolic scores for visceral fat and chronic kidney disease: A cross-sectional study.
    Yu P; Meng X; Kan R; Wang Z; Yu X
    Front Endocrinol (Lausanne); 2022; 13():1052736. PubMed ID: 36545336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of DXA-measured abdominal adiposity with cardio-metabolic risk and related markers in early adolescence in Project Viva.
    Wu AJ; Rifas-Shiman SL; Taveras EM; Oken E; Hivert MF
    Pediatr Obes; 2021 Feb; 16(2):e12704. PubMed ID: 32761791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neck circumference as a simple tool for identifying the metabolic syndrome and insulin resistance: results from the Brazilian Metabolic Syndrome Study.
    Stabe C; Vasques AC; Lima MM; Tambascia MA; Pareja JC; Yamanaka A; Geloneze B
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):874-81. PubMed ID: 22804918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body adiposity indicators and cardiometabolic risk: Cross-sectional analysis in participants from the PREDIMED-Plus trial.
    Konieczna J; Abete I; Galmés AM; Babio N; Colom A; Zulet MA; Estruch R; Vidal J; Toledo E; Díaz-López A; Fiol M; Casas R; Vera J; Buil-Cosiales P; Martín V; Goday A; Salas-Salvadó J; Martínez JA; Romaguera D;
    Clin Nutr; 2019 Aug; 38(4):1883-1891. PubMed ID: 30031660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of visceral adipose tissue magnitude using a new model based on simple clinical measurements.
    Torun C; Ankaralı H; Caştur L; Uzunlulu M; Erbakan AN; Akbaş MM; Gündüz N; Doğan MB; Bahadır MA; Oğuz A
    Front Endocrinol (Lausanne); 2024; 15():1411678. PubMed ID: 39119005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes.
    Bello-Chavolla OY; Almeda-Valdes P; Gomez-Velasco D; Viveros-Ruiz T; Cruz-Bautista I; Romo-Romo A; Sánchez-Lázaro D; Meza-Oviedo D; Vargas-Vázquez A; Campos OA; Sevilla-González MDR; Martagón AJ; Hernández LM; Mehta R; Caballeros-Barragán CR; Aguilar-Salinas CA
    Eur J Endocrinol; 2018 May; 178(5):533-544. PubMed ID: 29535168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of abdominal bioelectrical impedance analysis and comparison with other known parameters in predicting the metabolic syndrome.
    Mousa U; Kut A; Bozkus Y; Cicek Demir C; Anil C; Bascil Tutuncu N
    Exp Clin Endocrinol Diabetes; 2013 Jul; 121(7):391-6. PubMed ID: 23696479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-energy X-ray absorptiometry for quantification of visceral fat.
    Kaul S; Rothney MP; Peters DM; Wacker WK; Davis CE; Shapiro MD; Ergun DL
    Obesity (Silver Spring); 2012 Jun; 20(6):1313-8. PubMed ID: 22282048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abdominal visceral fat measurement using dual-energy X-ray: association with cardiometabolic risk factors.
    Rothney MP; Catapano AL; Xia J; Wacker WK; Tidone C; Grigore L; Xia Y; Ergun DL
    Obesity (Silver Spring); 2013 Sep; 21(9):1798-802. PubMed ID: 23696250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased visceral fat accumulation modifies the effect of insulin resistance on arterial stiffness and hypertension risk.
    Antonio-Villa NE; Bello-Chavolla OY; Vargas-Vázquez A; Mehta R; Fermín-Martínez CA; Martagón-Rosado AJ; Barquera-Guevara DA; Aguilar-Salinas CA;
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):506-517. PubMed ID: 33279372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visceral Obesity Mediates the Association Between Metabolic Syndrome and Obstructive Sleep Apnea Syndrome.
    Bozkurt NC; Beysel S; Karbek B; Unsal İO; Cakir E; Delibasi T
    Metab Syndr Relat Disord; 2016 May; 14(4):217-21. PubMed ID: 27003688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The newly proposed Metabolic Score for Visceral Fat is a reliable tool for identifying non-alcoholic fatty liver disease, requiring attention to age-specific effects in both sexes.
    Kuang M; Qiu J; Li D; Hu C; Zhang S; Sheng G; Zou Y
    Front Endocrinol (Lausanne); 2023; 14():1281524. PubMed ID: 38089634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of various adiposity indices in identifying cardiometabolic diseases in Arab adults.
    Al-Daghri NM; Al-Attas OS; Wani K; Alnaami AM; Sabico S; Al-Ajlan A; Chrousos GP; Alokail MS
    Cardiovasc Diabetol; 2015 Aug; 14():101. PubMed ID: 26249167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.